title: Labetalol to control blood pressure after cerebrovascular surgery.
abstract: Fifteen patients who had undergone neurovascular surgery for arteriovenous malformations or cerebrovascular aneurysms and had intracranial pressure (ICP) monitors were studied. The patients had been treated initially with sodium nitroprusside to maintain their arterial BP in a prescribed range, but, because of excessive nitroprusside dose requirements, they were considered either to have refractory BP or to be at risk for thiocyanate toxicity. Intravenous labetalol therapy was started either by frequent bolus pulse therapy every 1 to 2 h or by continuous infusion therapy. The degree of desired arterial BP control and the effects on ICP and cerebral perfusion pressure (CPP) were assessed and compared with the results during nitroprusside therapy. The degree of arterial BP control with labetalol was assessed to be good; 11 patients were weaned off nitroprusside and the remaining four patients had a substantial reduction in their nitroprusside requirements, needing an average of only 1.5 micrograms/kg.min of nitroprusside to control their BP compared with average requirements of 10 micrograms/kg.min of nitroprusside before labetalol therapy. Labetalol therapy improved CPP in six patients and ICP in five patients, with no significant change in cerebral pressure in the remainder. Overall, the CPP in the 15 patients improved from 63 +/- 15 (SD) mm Hg with nitroprusside to 65 +/- 10 mm Hg with labetalol therapy and the ICP decreased from 11.3 +/- 6.1 mm Hg with nitroprusside to 8.6 +/- 3.1 mm Hg with labetalol therapy (p less than .05 by Wilcoxon matched pairs).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Division of Anesthesiology, Cleveland Clinic Foundation, OH 44106.
authors.forename: J P
authors.initials: JP
authors.lastname: Orlowski
authors.forename: D
authors.initials: D
authors.lastname: Shiesley
authors.forename: D G
authors.initials: DG
authors.lastname: Vidt
authors.forename: G H
authors.initials: GH
authors.lastname: Barnett
authors.forename: J R
authors.initials: JR
authors.lastname: Little
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001165:Arteriovenous Malformations / Q000601:surgery; D001921:Brain / Q000601:surgery*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007262:Infusions, Intravenous; D007275:Injections, Intravenous; D002532:Intracranial Aneurysm / Q000601:surgery; D007427:Intracranial Pressure / Q000187:drug effects; D007741:Labetalol / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009599:Nitroprusside / Q000627:therapeutic use; D011183:Postoperative Complications / Q000188:drug therapy*
chemical_list: D009599:Nitroprusside; D007741:Labetalol